TB Champions provide crucial support to patients by ensuring they adhere to their prescribed TB and other related therapies. This support includes regular check-ins, reminders, and guidance to help patients complete their treatment regimens successfully, thereby preventing the development of drug-resistant TB strains.
TB Champions are vigilant watchdogs, reporting any issues related to TB services, such as human rights violations or shortages of TB commodities. Their reports help in identifying and addressing gaps in service delivery, ensuring that patients receive the necessary resources and respectful treatment.
By closely monitoring patients, TB Champions can identify complications, including adverse drug reactions. They promptly refer affected individuals to appropriate health facilities for timely and specialized care, thereby preventing further health deterioration.

TB Champions actively participate in periodic review meetings organized by the County Health Management Team (CHMT). Their involvement ensures that the voices and experiences of those on the frontlines of TB care are heard, contributing to more informed and effective health strategies and policies
Through community sensitization activities, TB Champions play a vital role in raising awareness about TB and available services. They educate communities about TB prevention, symptoms, and treatment options, reducing stigma and encouraging early diagnosis and treatment.

TB Champions oversee and track the utilization of funds allocated for TB in counties. They ensure that financial resources are used effectively and transparently, advocating for accountability and proper allocation to enhance TB control efforts.
TB Champions are trained to identify individuals who exhibit symptoms of TB and refer them to health facilities for diagnosis and management. This early identification and referral are crucial for controlling the spread of TB and initiating prompt treatment.
TB Champions facilitate Directly Observed Therapy, a strategy where they directly observe patients taking their TB medications. This ensures that patients adhere to their treatment regimens, improving treatment outcomes and reducing the risk of drug resistance.